Incidence of death or BPD does not differ with expectant management versus active treatment for preterm infants with protocol-defined PDA.

Severe valvular heart disease (VHD) is prevalent among patients with cancer and is associated with reduced survival.

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

Risk-based screening is noninferior to annual screening for detecting stage ≥IIB cancers, does not reduce biopsy rates despite fewer mammograms.

Ketamine for anesthesia does not lower in-hospital death by day 28 compared with etomidate among critically ill adults undergoing tracheal intubation.

Nearly 1 in 4 Americans believe the US health care system is in crisis, and high costs are the top reason why.

For patients with node-negative breast cancer, omission of sentinel lymph node biopsy results in noninferior 5-year recurrence rates and survival.

Older age, certain comorbidities, and immunosuppression increase risk for severe West Nile disease and mortality.

The CDC has rescinded its long-standing advice on universal hepatitis B vaccination of newborns within 24 hours of birth.

The FDA is expected to decide on treatments for breast cancer, EBV+ post-transplant lymphoproliferative disease, focal segmental glomerulosclerosis, presbyopia, and severe allergic reactions.

Flu season is getting an early start in New York City, with emergency rooms seeing a sharp jump in flu patients.

Giredestrant shows significant improvement in iDFS in patients with early-stage, HR-positive, HER2-negative breast cancer.